| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Dentistry (H.L., P.M.B., C.Z.Z., W.G.Y.) and Physiology and Pharmacology (R.W.C., M.J.W.), University of Queensland, St. Lucia, Queensland 4072, Australia
Address all correspondence and requests for reprints to: Prof. M. J. Waters, Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Queensland 4072, Australia. E-mail m.waters{at}mailbox.uq.edu.au
GH is known to increase the formation of bone and hard tissues of the tooth (dentine, cementum, and enamel), as do bone morphogenetic proteins. GH receptors are expressed in these tissues and could mediate local growth responses. Here we report that both GH and insulin-like growth factor I (IGF-I) are able to increase expression of bone morphogenetic protein-2 and -4 messenger RNAs 4- to 5-fold in human dental pulp fibroblasts in vitro. Induction was seen at physiological concentrations of hormone (25–100 ng/ml GH; 50–200 ng/ml IGF-I) and reached a maximum at 4–8 h. Immunoblot analysis demonstrated that the increase in messenger RNAs resulted in an increase in expressed protein. Anti-IGF-I inhibition experiments indicate that GH is able to induce the response without a requirement for local IGF-I production. These results raise the possibility that bone morphogenetic proteins mediate the local osteogenic actions of GH and IGF-I, and lend support to the view that GH can act through the mediation of factors other than IGF-I. These factors may combine with IGF-I in different tissues to enhance GH action and specificity.
This article has been cited by other articles:
 |
|
 |
|
  A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Raschke, M. H. Rasmussen, S. Govender, D. Segal, M. Suntum, and J. S. Christiansen Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial Eur. J. Endocrinol., March 1, 2007; 156(3): 341 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yaar, C. Wu, H.-Y. Park, I. Panova, G. Schutz, and B. A. Gilchrest Bone Morphogenetic Protein-4, a Novel Modulator of Melanogenesis J. Biol. Chem., September 1, 2006; 281(35): 25307 - 25314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Rowland, L. M. Kerr, M. White, P. G. Noakes, and M. J. Waters Heterozygote Effects in Mice with Partial Truncations in the Growth Hormone Receptor Cytoplasmic Domain: Assessment of Growth Parameters and Phenotype Endocrinology, December 1, 2005; 146(12): 5278 - 5286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Q. Xu, B. S. Emerald, E. L. K. Goh, N. Kannan, L. D. Miller, P. D. Gluckman, E. T. Liu, and P. E. Lobie Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma J. Biol. Chem., June 24, 2005; 280(25): 23987 - 24003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.R. Smid, J.E. Rowland, W.G. Young, T.J. Daley, K.T. Coschigano, J.J. Kopchick, and M.J. Waters Mouse Cellular Cementum is Highly Dependent on Growth Hormone Status Journal of Dental Research, January 1, 2004; 83(1): 35 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Graichen, D. Liu, Y. Sun, K.-O. Lee, and P. E. Lobie Autocrine Human Growth Hormone Inhibits Placental Transforming Growth Factor-beta Gene Transcription to Prevent Apoptosis and Allow Cell Cycle Progression of Human Mammary Carcinoma Cells J. Biol. Chem., July 12, 2002; 277(29): 26662 - 26672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lovschall, O. Fejerskov, and A. Flyvbjerg Pulp-capping with Recombinant Human Insulin- like Growth Factor I (rhIGF-I) in Rat Molars Advances in Dental Research, August 1, 2001; 15(1): 108 - 112. [Abstract] [PDF]
|
|
|
|
|
|
W.G. Young, H. Li, Y. Xiao, M.J. Waters, and P.M. Bartold Growth-hormone-stimulated Dentinogenesis in Lewis Dwarf Rat Molars Journal of Dental Research, August 1, 2001; 80(8): 1742 - 1747. [Abstract] [PDF]
|
|
|
|
|
|
S. Ivanovski, H.R. Haase, and P.M. Bartold Expression of Bone Matrix Protein mRNAs by Primary and Cloned Cultures of the Regenerative Phenotype of Human Periodontal Fibroblasts Journal of Dental Research, July 1, 2001; 80(7): 1665 - 1671. [Abstract] [PDF]
|
|
|
|
|
|
D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler The Somatomedin Hypothesis: 2001 Endocr. Rev., February 1, 2001; 22(1): 53 - 74. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-L. Liu, S. Yakar, and D. LeRoith Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System Experimental Biology and Medicine, April 1, 2000; 223(4): 344 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Liu and D. LeRoith Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone Endocrinology, November 1, 1999; 140(11): 5178 - 5184. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Shimasaki, R. J. Zachow, D. Li, H. Kim, S.-i. Iemura, N. Ueno, K. Sampath, R. J. Chang, and G. F. Erickson A functional bone morphogenetic protein system in the ovary PNAS, June 22, 1999; 96(13): 7282 - 7287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Mertani, T. Zhu, E. L. K. Goh, K.-O. Lee, G. Morel, and P. E. Lobie Autocrine Human Growth Hormone (hGH) Regulation of Human Mammary Carcinoma Cell Gene Expression. IDENTIFICATION OF CHOP AS A MEDIATOR OF hGH-STIMULATED HUMAN MAMMARY CARCINOMA CELL SURVIVAL J. Biol. Chem., June 8, 2001; 276(24): 21464 - 21475. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
